SCHEMBL9558908

SCHEMBL9558908

C1=CC2=C(C=NCN2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2730082 0.71
SCHEMBL28010930 0.59
SCHEMBL18327710 0.57
SCHEMBL279520 0.57
SCHEMBL932677 0.57
SCHEMBL15614937 0.56
SCHEMBL7624224 0.55
SCHEMBL2540204 0.54
SCHEMBL23263210 0.52
SCHEMBL388290 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4058455-A1 NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE Temple University - Of The Commonwealth System of Higher Education (US) 2022-09-21 EP disclosed
WO-2013027168-A1 NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS PFIZER INC. (US) 2013-02-28 WO disclosed
US-5185338-A Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1993-02-09 US disclosed
US-5041443-A Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1991-08-20 US disclosed